Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00433225 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation
A Phase 4 study, sponsored by Innovative Medical.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00433225: Completed Phase 4 study, sponsored by Innovative Medical.
NCT00433225 is a Phase 4 study that has completed, run by Innovative Medical. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00433225, a Phase 4 study, has completed, sponsored by Innovative Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
The purpose of this study was to evaluate the efficacy of ketorolac 0.4% on quality of vision and macula thickening in patients undergoing cataract surgery using the ReStor® multifocal IOL.
Interventions
- DRUG Prednisolone Acetate
- DRUG Ketorolac 0.4%
- DRUG Gatifloxacin 0.3%
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 4 |
What the finished NCT00433225 record still lists
NCT00433225 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 3 interventions - of which Prednisolone Acetate is the first listed.
NCT00433225 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00433225 about?
NCT00433225 is a clinical study titled "Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation". The purpose of this study was to evaluate the efficacy of ketorolac 0.4% on quality of vision and macula thickening in patients undergoing cataract surgery using the ReStor® multifocal IOL.
What is the current status of trial NCT00433225?
This trial is currently completed. It is a Phase 4 study.
What interventions are being tested in trial NCT00433225?
The interventions under investigation include: Prednisolone Acetate (DRUG), Ketorolac 0.4% (DRUG), Gatifloxacin 0.3% (DRUG).
Who is sponsoring clinical trial NCT00433225?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.